Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FP1SH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,863
Award facts
- Contract value 100% obligated
- $11,862.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,862.89 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on January 26, 2026, with completion scheduled for January 27, 2026. This firm fixed-price, non-set-aside contract was awarded competitively and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, representing part of the company's ongoing pharmaceutical supply role to federal military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle through December 2031 that enables comprehensive pharmaceutical and medical supply distribution globally. AmerisourceBergen serves as a critical vendor in the federal pharmaceutical supply chain, fulfilling prescription medication needs across multiple therapeutic domains for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The company's extensive contract portfolio with DLA demonstrates its established capability to meet government procurement requirements for specialty medications, brand-name and generic drugs, vaccines, and medical supplies supporting military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FP1SH?
SPE2DR26FP1SH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FP1SH worth?
The government has obligated $11,863 on SPE2DR26FP1SH.
Is contract SPE2DR26FP1SH an order under another contract?
Yes. SPE2DR26FP1SH is a delivery order under SPE2DR25D3014, an indefinite delivery contract.
Was contract SPE2DR26FP1SH competed?
The extent of competition for SPE2DR26FP1SH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award